Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Headshot of Sarah Jackson

Sarah Jackson, Ph.D., M.P.H.

Earl Stadtman Investigator
Infections and Immunoepidemiology Branch

NCI Shady Grove

sarah.jackson@nih.gov
Principal Investigators in IIB

Meet the PIs of IIB and learn about their research

Biography

Sarah Jackson, Ph.D., M.P.H., joined DCEG as a postdoctoral fellow in the Infections and Immunoepidemiology Branch (IIB) in 2018, and was inducted into the NIH Independent Research Scholar Program and promoted to research fellow in 2021. She was selected as an Earl Stadtman tenure-track investigator and an NIH Distinguished Scholar in 2023. Dr. Jackson earned an M.P.H. in epidemiology in 2008 from the George Washington University, Washington, D.C., and a Ph.D. in epidemiology in 2018 from the University of Maryland, Baltimore.

Dr. Jackson has received numerous awards for her work, including the Sallie Rosen Kaplan Fellowship for Women Scientists in Cancer Research, NIH Fellows Award for Research Excellence, the NCI Director’s Intramural Innovation Award, William G. Coleman Jr. Ph.D., Minority Health and Health Disparities Research Innovation Award, and the DCEG Intramural Research Award.

Research Interests

Dr. Jackson’s research seeks to understand how the mechanisms by which sex differences impact cancer risk and outcomes. Specifically, her research addresses how sex differences (hormones, chromosomes, etc.) influence cancer risk and survival.

Sex Differences in Cancer Incidence and Survival

Men and Cancer

Read Dr. Jackson's comments in the article "Men and Cancer", appearing in Cancer Today, a publication of the American Association for Cancer Research®.

Sex differences are especially stark in cancer incidence and survival where men have at least a two-to-three times higher risk than women of developing and dying from most non-reproductive cancers. Historically, this male predominance has been attributed to increased risk-taking behaviors among men contrasted with the health-seeking behaviors of women. However, a growing body of research has found that differences in hormones, chromosomes, and gene expression between males and females affect immune response to infections and cancer. Dr. Jackson’s research seeks to understand the relative contributions of these factors in the sex differences in non-reproductive cancer incidence and survival.

Current Fellows

Julia Francis, M.P.H.

Beth Maclin, Ph.D., M.P.H.

Ishita Singh, D.P.H., M.P.H., B.D.S.

Former Fellows

Reneé Brown, B.S.

Sararat (Joy) Tosakoon, B.S.

Information for Journalists

To request an interview with a DCEG investigator, please complete this form: Request For Comment | HHS.gov.

  • Updated:
Email